EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Gut Microbiota Metabolite Urolithin B Prevents Colorectal Carcinogenesis by Remodeling Microbiota and PD-L1/HLA-B

Lixue Wang, Jinlong Chen, Qijun Chen, Hui Song, Ziqian Wang, Wen Xing, Siyao Jin, Xueying Song, Hua Yang, Wenhua Zhao iD

Oxidative Medicine and Cellular Longevity · 2023

DOI: 10.1155/2023/6480848 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oxidative Medicine and Cellular Longevity, 2023. Verfasst von Lixue Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Capital Medical University, Beijing 100069, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Microbiota, Colonic Neoplasms, Colorectal Neoplasms. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions, Beijing Municipal Commission of Education, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer has risen to the third occurring cancer in the world. Fluorouracil (5-Fu), oxaliplatin, and cisplatin are the most effective chemotherapeutic agents for clinical chemotherapy. Nevertheless, due to chemotherapeutic drug resistance, the survival rate of patients with CRC remains very low. In this study, we used the inflammation-induced or mutation-family-inherited murine CRC models to study the anticancer and immunotherapy effects of urolithin B (UB), the final metabolite of polyphenols in the gastrointestinal tract. The label-free proteomics analysis and the gene ontology (GO) classifications were used to test and analyze the proteins affected by UB. And 16S rDNA sequencing and flow cytometry were utilized to uncover gut microbiome composition and immune defense improved by UB administration. The results indicated that urolithin B prevents colorectal carcinogenesis by remodeling gut microbial and tumor immune microenvironments, such as HLA-B, NK cells, regulatory T cells, and γδ TCR cells, and decreasing the PD-L1. The combination of urolithin B with first-line therapeutic drugs improved the colorectal intestinal hematochezia by shaping gut microbiota, providing a strategy for the treatment of immunotherapy treatment for CRC treatments. UB combined with anti-PD-1 antibody could inhibit the growth of colon cancer. Urolithin B may thus contribute to anticancer treatments and provide a high immune response microenvironment for CRC patients’ further immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeMicrobiotaColonic NeoplasmsColorectal NeoplasmsHumansAnimalsMiceB7-H1 AntigenCarcinogenesisFluorouracilTumor MicroenvironmentCoumarins

Substanzen

B7-H1 AntigenFluorouracilurolithin BCoumarins

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Capital Medical University, Beijing 100069, China.
  • School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China.
  • Clinical Research Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, China 100045.
  • Central Laboratory, Capital Medical University, Beijing 100069, China.

ORCID-Profile: Wenhua Zhao

Förderung

  • Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions
  • Beijing Municipal Commission of Education
  • National Natural Science Foundation of China
  • Shanghai Model Organisms Center
  • Meiji Biological Company
  • Capital Medical University

Zitieren

APA

Wang, L., Chen, J., Chen, Q., Song, H., Wang, Z., Xing, W., Jin, S., Song, X., Yang, H., & Zhao, W. (2023). The Gut Microbiota Metabolite Urolithin B Prevents Colorectal Carcinogenesis by Remodeling Microbiota and PD-L1/HLA-B. Oxidative Medicine and Cellular Longevity. https://doi.org/10.1155/2023/6480848

Vancouver

Wang L, Chen J, Chen Q, Song H, Wang Z, Xing W, et al. The Gut Microbiota Metabolite Urolithin B Prevents Colorectal Carcinogenesis by Remodeling Microbiota and PD-L1/HLA-B. Oxidative Medicine and Cellular Longevity. 2023. doi:10.1155/2023/6480848

BibTeX
@article{Wang2023,
  author = {Wang, Lixue and Chen, Jinlong and Chen, Qijun and Song, Hui and Wang, Ziqian and Xing, Wen and Jin, Siyao and Song, Xueying and Yang, Hua and Zhao, Wenhua},
  title = {The Gut Microbiota Metabolite Urolithin B Prevents Colorectal Carcinogenesis by Remodeling Microbiota and PD-L1/HLA-B},
  journal = {Oxidative Medicine and Cellular Longevity},
  year = {2023},
  doi = {10.1155/2023/6480848}
}
Kostenlos starten →